Development of a Test that Measures Real-Time HER2 Signaling Function in Live Breast Cancer Cell Lines and Primary Cells

Measurement of HER2 signaling activity in the tumor cells of patients with breast cancer is a feasible approach to explore as a biomarker to identify HER2-driven cancers not currently diagnosable with genomic techniques.

 BMC Cancer